| 000 | 02678 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250516111612.0 | ||
| 264 | 0 | _c20121219 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2012.42.6031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoff, Paulo M | |
| 245 | 0 | 0 |
_aCediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2012 |
||
| 300 |
_a3596-603 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBrazil |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xpathology |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aHochhaus, Andreas | |
| 700 | 1 | _aPestalozzi, Bernhard C | |
| 700 | 1 | _aTebbutt, Niall C | |
| 700 | 1 | _aLi, Jin | |
| 700 | 1 | _aKim, Tae Won | |
| 700 | 1 | _aKoynov, Krassimir D | |
| 700 | 1 | _aKurteva, Galina | |
| 700 | 1 | _aPintér, Tamás | |
| 700 | 1 | _aCheng, Ying | |
| 700 | 1 | _avan Eyll, Brigitte | |
| 700 | 1 | _aPike, Laura | |
| 700 | 1 | _aFielding, Anitra | |
| 700 | 1 | _aRobertson, Jane D | |
| 700 | 1 | _aSaunders, Mark P | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 30 _gno. 29 _gp. 3596-603 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2012.42.6031 _zAvailable from publisher's website |
| 999 |
_c22093470 _d22093470 |
||